Praveen Kumar1, Alexander J Sundermann2, Elise M Martin3, Graham M Snyder3, Jane W Marsh2,3, Lee H Harrison2, Mark S Roberts1. 1. Department of Health Policy and Management, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. 2. The Microbial Genomic Epidemiology Laboratory, University of Pittsburgh School of Medicine and Graduate School of Public Health, Pittsburgh, Pennsylvania, USA. 3. Department of Infection Prevention and Control, University of Pittsburgh Medical Center Presbyterian Hospital, Pittsburgh, Pennsylvania, USA.
Abstract
BACKGROUND: Whole genome sequencing (WGS) surveillance and electronic health record data mining have the potential to greatly enhance the identification and control of hospital outbreaks. The objective was to develop methods for examining economic value of a WGS surveillance-based infection prevention (IP) program compared to standard of care (SoC). METHODS: The economic value of a WGS surveillance-based IP program was assessed from a hospital's perspective using historical outbreaks from 2011-2016. We used transmission network of outbreaks to estimate incremental cost per transmission averted. The number of transmissions averted depended on the effectiveness of intervening against transmission routes, time from transmission to positive culture results and time taken to obtain WGS results and intervene on the transmission route identified. The total cost of an IP program included cost of staffing, WGS, and treating infections. RESULTS: Approximately 41 out of 89 (46%) transmissions could have been averted under the WGS surveillance-based IP program, and it was found to be a less costly and more effective strategy than SoC. The results were most sensitive to the cost of performing WGS and the number of isolates sequenced per year under WGS surveillance. The probability of the WGS surveillance-based IP program being cost-effective was 80% if willingness to pay exceeded $2400 per transmission averted. CONCLUSIONS: The proposed economic analysis is a useful tool to examine economic value of a WGS surveillance-based IP program. These methods will be applied to a prospective evaluation of WGS surveillance compared to SoC.
BACKGROUND: Whole genome sequencing (WGS) surveillance and electronic health record data mining have the potential to greatly enhance the identification and control of hospital outbreaks. The objective was to develop methods for examining economic value of a WGS surveillance-based infection prevention (IP) program compared to standard of care (SoC). METHODS: The economic value of a WGS surveillance-based IP program was assessed from a hospital's perspective using historical outbreaks from 2011-2016. We used transmission network of outbreaks to estimate incremental cost per transmission averted. The number of transmissions averted depended on the effectiveness of intervening against transmission routes, time from transmission to positive culture results and time taken to obtain WGS results and intervene on the transmission route identified. The total cost of an IP program included cost of staffing, WGS, and treating infections. RESULTS: Approximately 41 out of 89 (46%) transmissions could have been averted under the WGS surveillance-based IP program, and it was found to be a less costly and more effective strategy than SoC. The results were most sensitive to the cost of performing WGS and the number of isolates sequenced per year under WGS surveillance. The probability of the WGS surveillance-based IP program being cost-effective was 80% if willingness to pay exceeded $2400 per transmission averted. CONCLUSIONS: The proposed economic analysis is a useful tool to examine economic value of a WGS surveillance-based IP program. These methods will be applied to a prospective evaluation of WGS surveillance compared to SoC.
Authors: Elaine R Cohen; Joe Feinglass; Jeffrey H Barsuk; Cynthia Barnard; Anna O'Donnell; William C McGaghie; Diane B Wayne Journal: Simul Healthc Date: 2010-04 Impact factor: 1.929
Authors: Deverick J Anderson; Luke F Chen; David J Weber; Rebekah W Moehring; Sarah S Lewis; Patricia F Triplett; Michael Blocker; Paul Becherer; J Conrad Schwab; Lauren P Knelson; Yuliya Lokhnygina; William A Rutala; Hajime Kanamori; Maria F Gergen; Daniel J Sexton Journal: Lancet Date: 2017-01-17 Impact factor: 79.321
Authors: Alexander J Sundermann; Ahmed Babiker; Jane W Marsh; Kathleen A Shutt; Mustapha M Mustapha; Anthony W Pasculle; Chinelo Ezeonwuka; Melissa I Saul; Marissa P Pacey; Daria Van Tyne; Ashley M Ayres; Vaughn S Cooper; Graham M Snyder; Lee H Harrison Journal: Clin Infect Dis Date: 2020-05-23 Impact factor: 9.079
Authors: Shelley S Magill; Jonathan R Edwards; Wendy Bamberg; Zintars G Beldavs; Ghinwa Dumyati; Marion A Kainer; Ruth Lynfield; Meghan Maloney; Laura McAllister-Hollod; Joelle Nadle; Susan M Ray; Deborah L Thompson; Lucy E Wilson; Scott K Fridkin Journal: N Engl J Med Date: 2014-03-27 Impact factor: 91.245
Authors: Michael Baym; Sergey Kryazhimskiy; Tami D Lieberman; Hattie Chung; Michael M Desai; Roy Kishony Journal: PLoS One Date: 2015-05-22 Impact factor: 3.240
Authors: Richard E Nelson; Makoto Jones; Molly Leecaster; Matthew H Samore; William Ray; Angela Huttner; Benedikt Huttner; Karim Khader; Vanessa W Stevens; Dale Gerding; Marin L Schweizer; Michael A Rubin Journal: PLoS One Date: 2016-03-31 Impact factor: 3.240
Authors: Jane W Marsh; Mary G Krauland; Jemma S Nelson; Jessica L Schlackman; Anthony M Brooks; A William Pasculle; Kathleen A Shutt; Yohei Doi; Ashley M Querry; Carlene A Muto; Lee H Harrison Journal: PLoS One Date: 2015-12-04 Impact factor: 3.240
Authors: Alexander J Sundermann; Jieshi Chen; Praveen Kumar; Ashley M Ayres; Shu Ting Cho; Chinelo Ezeonwuka; Marissa P Griffith; James K Miller; Mustapha M Mustapha; A William Pasculle; Melissa I Saul; Kathleen A Shutt; Vatsala Srinivasa; Kady Waggle; Daniel J Snyder; Vaughn S Cooper; Daria Van Tyne; Graham M Snyder; Jane W Marsh; Artur Dubrawski; Mark S Roberts; Lee H Harrison Journal: Clin Infect Dis Date: 2022-08-31 Impact factor: 20.999
Authors: Sang Mee Hwang; Hee Won Cho; Tae Yeul Kim; Jeong Su Park; Jongtak Jung; Kyoung-Ho Song; Hyunju Lee; Eu Suk Kim; Hong Bin Kim; Kyoung Un Park Journal: Diagnostics (Basel) Date: 2021-01-29
Authors: Louisa G Gordon; Thomas M Elliott; Brian Forde; Brett Mitchell; Philip L Russo; David L Paterson; Patrick N A Harris Journal: BMJ Open Date: 2021-02-01 Impact factor: 2.692
Authors: Thomas M Elliott; Patrick N Harris; Leah W Roberts; Michelle Doidge; Trish Hurst; Krispin Hajkowicz; Brian Forde; David L Paterson; Louisa G Gordon Journal: Antimicrob Steward Healthc Epidemiol Date: 2021-12-13